- FDA Roundup: March 24, 2023
- FDA Works to Further Improve Nutrition, Reduce Diet-Related Chronic Disease with Dietary Guidance Statements on Food Labels
- Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle
- Colorectal Cancer: What You Should Know About Screening
- Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
- Medical Devices
- Nitrosamine Impurities: Latest USP Tool Further Aids Understanding and Control
- Innovative Matrix Framework Assesses Risk for Substandard Antibiotics
- What’s driving drug shortages during the cold and flu season?